Fructose-induced alterations of glucose and lipid homeostasis: progressive organ dysfunction leading to metabolic diseases or mere adaptive changes?
In the 1970s and 1980s, the monosaccharide fructose, because of its low glycemic effect, attracted much interest as a potential sweetener for patients with diabetes mellitus (1). Many decades later, its widespread use in the food supply, both as a component of sucrose as well as in high-fructose corn syrup, has become a major suspect in the current epidemic of obesity, type 2 diabetes mellitus, nonalcoholic fatty liver disease, and cardiovascular diseases (2).
Source: American Journal of Clinical Nutrition - Category: Nutrition Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Epidemics | Epidemiology | Fatty Liver Disease (FLD) | Heart | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Obesity | Sweeteners | Urology & Nephrology